Clinical Trials on Chronic Disease Obstructive Pulmonary in Canada
Total 3350 results
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseGermany, Belgium, Spain, Canada, United Kingdom
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Romania, Hungary, Bulgaria, Spain, Finland, Puerto Rico
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Bulgaria, Germany, Hungary, Romania, Denmark, Greece, Mexico, Iceland
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Poland, Romania, Canada, Philippines, Spain, Ukraine, Vietnam
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Australia, Canada, New Zealand
-
MedImmune LLCAstraZenecaCompletedRespiratory Syncytial Virus, Chronic Obstructive Pulmonary Disease, Congestive Heart FailureUnited States, Bulgaria, France, Russian Federation, Canada, Sweden, Germany, Italy, Czech Republic
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)Sweden, France, Italy, Spain, Turkey, United Kingdom, Germany, Denmark, Finland, Netherlands, Norway, Austria, Belgium, Portugal, Greece, Ireland, Switzerland
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease (COPD)United States, Argentina, Australia, Canada, Mexico, New Zealand, South Africa
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseKorea, Republic of, Austria, Belgium, Germany, Greece, Russian Federation, Australia, Brazil, Canada, Denmark, France, Hungary, Israel, Italy, Netherlands, Poland, Slovakia, South Africa, Spain, Turkey, United Kingdom
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Canada
-
McMaster UniversityCanadian Institutes of Health Research (CIHR)RecruitingDiabetes Mellitus | Chronic Kidney Diseases | Chronic Obstructive Pulmonary Disease | Osteoarthritis | Dementia | Congestive Heart Failure | Depression, AnxietyCanada
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Australia, Canada, New Zealand
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)TerminatedChronic Obstructive Pulmonary Disease (COPD) | Non-small Cell Lung Cancer (NSCLC)United States, Canada
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Czech Republic, Poland, South Africa, Netherlands
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Canada
-
Pearl Therapeutics, Inc.CompletedChronic Obstructive Pulmonary Disease (COPD)United States, Australia, New Zealand
-
McMaster UniversityWest Park Healthcare CentreCompleted
-
SanofiRegeneron PharmaceuticalsRecruitingChronic Obstructive Pulmonary DiseaseKorea, Republic of, Turkey, United States, Chile, Czechia, Israel, Russian Federation, Argentina, Brazil, Bulgaria, Canada, Denmark, Estonia, France, Georgia, Germany, Hungary, India, Japan, Latvia, Lithuania, Mexico, Netherlands, Norway and more
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease (COPD)Germany, Colombia, India, Korea, Republic of, Poland, Romania, South Africa, Italy, Austria, Belgium, Croatia, Estonia, Hungary, Russian Federation, Taiwan, Turkey, Japan, Spain, Sweden, United Kingdom, China, Thailand, Canada, Hong Kong and more
-
SanofiRegeneron PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseSpain, Argentina, China, Mexico, Canada, Ukraine, Israel, Italy, Czechia, Korea, Republic of, Bulgaria, Chile, Denmark, Finland, Germany, Hungary, Japan, Poland, Romania, Russian Federation, Slovakia, Sweden, Turkey, United States
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPDUnited States, Argentina, Canada, Colombia, Mexico, Peru
-
SanofiRegeneron PharmaceuticalsActive, not recruitingChronic Obstructive Pulmonary DiseaseGreece, Belgium, Spain, Argentina, Hungary, South Africa, United Kingdom, France, Latvia, Germany, Netherlands, Russian Federation, Ukraine, United States, Australia, Brazil, Bulgaria, Canada, Chile, Colombia, Czechia, Lithuania, Me... and more
-
McMaster UniversityFisher and Paykel HealthcareActive, not recruiting
-
Queen's UniversityOntario Ministry of Health and Long Term CareCompletedHeart Failure | Chronic Obstructive Lung DiseaseCanada
-
University of AlbertaAlberta Health services; University of Calgary; Alberta Innovates Health SolutionsCompletedPulmonary Disease, Chronic ObstructiveCanada
-
MedImmune LLCAstraZenecaCompletedPulmonary Disease, Chronic ObstructiveUnited States, Poland, Spain, United Kingdom, Denmark, Canada, Germany
-
Boehringer IngelheimPfizerCompletedPulmonary Disease, Chronic ObstructiveUnited States, Canada
-
Centre de Recherche de l'Institut Universitaire...Unknown
-
Lille Catholic UniversityUniversity of Lille Nord de FranceNot yet recruitingPulmonary Disease, Chronic Obstructive | Pulmonary FibrosisCanada, France
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseFrance
-
Unity Health TorontoCompletedChronic Obstructive Pulmonary Disease (COPD) | Congestive Heart Failure (CHF) | Diabetes Mellitus (DM)Canada
-
Laval UniversitySaey, Didier, M.D.; Oueslati, Ferid, PhDUnknownPulmonary Disease, Chronic ObstructiveCanada
-
AstraZenecaCompletedChronic Obstructive Pulmonary DiseaseUnited States, Peru, South Africa, Argentina, Mexico, Brazil, Chile, Colombia, Venezuela
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Belgium, Canada, Denmark, Germany, Hungary, Netherlands
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseGermany, Belgium, Colombia, Romania, South Africa, Italy, Hungary, Taiwan, Turkey, Switzerland, Australia, France, Israel, Sweden, China, Thailand, Estonia, Netherlands, Russian Federation, Slovakia, Spain, Argentina, Lithuania, Austria, Cana... and more
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveSouth Africa, United States, Canada, Ukraine, United Kingdom, Denmark, Czechia
-
University Health Network, TorontoWomen's College Hospital; Markham Stouffville Hospital; William Osler Health... and other collaboratorsRecruitingHypertension | Diabetes Mellitus | Chronic Obstructive Pulmonary Disease | Heart Failure，Congestive | Mental Health (Depression)Canada
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease | COPD | Moderate to Very Severe COPDUnited States, Canada
-
SunovionCompletedChronic Obstructive Pulmonary Disease | Emphysema | BronchitisUnited States
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveSpain, Canada, Germany
-
PfizerTerminatedPulmonary Disease, Chronic ObstructiveAustralia, Canada, United Kingdom, Poland, Netherlands
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia, Canada, Germany, Poland, Romania, Spain, United States, Korea, Republic of, Netherlands
-
AstraZenecaMenarini GroupCompletedPulmonary Disease, Chronic ObstructiveGermany, Hungary, Spain, Canada
-
University of British ColumbiaWithdrawnPulmonary Disease, Chronic ObstructiveCanada
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Belgium, Canada, Czech Republic, Denmark, Finland, Germany, South Africa, Spain, United Kingdom
-
PfizerCompletedPulmonary Disease, Chronic ObstructiveUnited States, Sweden, Australia, Hungary, Bulgaria, South Africa, Poland, Slovakia, India, Canada, Argentina, Czech Republic, Chile, New Zealand, United Kingdom
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Germany, Russian Federation, Ukraine, United States, South Africa, Korea, Republic of, Romania, Canada, France, Italy, Chile, Denmark
-
GlaxoSmithKlineParexelCompletedPulmonary Disease, Chronic ObstructivePoland, United States, Russian Federation
-
PfizerCompletedPulmonary Disease, Chronic ObstructiveUnited States, Hungary, Taiwan, South Africa, Germany, Bulgaria, Japan, Sweden, Poland, Slovakia, Argentina, Canada, Czech Republic, Spain